BioPharma Resources

Drug Trial Radar · NCT07054515

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis

Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 147 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

147

Planned (sponsor's estimate)

Start

Jun 30, 2025

Primary completion

May 14, 2028

Study completion Jun 14, 2028

Sponsor

Lead sponsor
Azafaros B.V.Industry
Sponsor type
Industry
First posted
Jul 8, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 4 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

An 18-month double-blind, randomized, placebo-controlled, multicenter, Phase 3 study to evaluate the safety and efficacy of oral nizubaglustat (AZ-3102) in late-infantile and juvenile forms of Niemann-Pick type C disease and in late-infantile and juvenile-onset forms of GM1 gangliosidosis or GM2 gangliosidosis

Conditions

  • Niemann-Pick Type C Disease
  • GM1 Gangliosidosis
  • GM2 Gangliosidosis

Interventions

  • AZ-3102Drug

    Oral dispersible tablets

  • PlaceboDrug

    A matching placebo will be administered in the same regimen as the intervention

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants allocated to subprotocol AZA-001-301-NPCTime frame: Baseline to month 18
  2. Number of participants allocated to subprotocol AZA-001-301-GMxTime frame: Baseline to month 18

Locations

39 sites in 17 countries. Site status is shown where the registry gives one.

  • UCSF Children's Hospital and Research Center at Oakland

    Oakland, California · Recruiting

  • University of Minnesota Medical School

    Minneapolis, Minnesota · Recruiting

  • Mayo Clinic Childrens Center - PIN

    Rochester, Minnesota · Recruiting

  • Children's Medical Center Dallas

    Dallas, Texas · Recruiting

  • Lysosomal Rare Disorders Research and Treatment Center

    Fairfax, Virginia · Recruiting

  • Hospital Universitario Austral

    Ciudad Autónoma Buenos Aires, Buenos Aires, Argentina · Active not recruiting

  • Hospital de Niños de La Santisima Trinidad

    Córdoba, Córdoba Province, Argentina · Recruiting

  • Women's and Children's Hospital

    North Adelaide, South Australia, Australia · Recruiting

  • Royal Melbourne Hospital

    Parkville, Victoria, Australia · Recruiting

  • Royal Children's Hospital Melbourne - PIN

    Parkville, Victoria, Australia · Recruiting

  • Hospital Pequeno Príncipe

    Curitiba, Brazil · Not yet recruiting

  • Instituto Fernandes Figueira

    Rio de Janeiro, Rio de Janeiro, Brazil · Recruiting

  • Hospital de Clinicas de Porto Alegre (HCPA) - PPDS

    Porto Alegre, Rio Grande do Sul, Brazil · Recruiting

  • M.A.G.I.C. Clinic Ltd. Metabolics and Genetics in Calgary

    Calgary, Alberta, Canada · Recruiting

  • University of Alberta Medical Genetics Clinic

    Edmonton, Alberta, Canada · Not yet recruiting

  • Centre Hospitalier de l'Universite de Montreal-1000 rue Saint-Denis

    Montreal, Quebec, Canada · Not yet recruiting

  • AP-HP - Hôpital Armand Trousseau

    Paris, France · Recruiting

  • AP-HP - Hôpital de la Pitié Salpétrière

    Paris, France · Active not recruiting

  • SphinCS GmbH

    Höchheim, Germany · Recruiting

  • Amrita Institute of Medical Sciences and Research Centre

    Ernākulam, Kerala, India · Recruiting

  • All India Institute of Medical Sciences (AIIMS) - New Delhi

    New Delhi, National Capital Territory of Delhi, India · Recruiting

  • JK Lone Hospital

    Jaipur, Rajasthan, India · Recruiting

  • Christian Medical College and Hospital

    Vellore, Tamil Nadu, India · Recruiting

  • Fondazione IRCCS Istituto Neurologico Carlo Besta

    Milan, Italy · Recruiting

  • Centenario Hospital Miguel Hidalgo

    Aguascalientes, Mexico · Not yet recruiting

  • Hospital Universitario Dr. Jose Eleuterio González

    Monterrey, Nuevo León, Mexico · Not yet recruiting

  • The Children's Hospital & the University of Child Health Lahore

    Lahore, Punjab Province, Pakistan · Not yet recruiting

  • ULS de Santa Maria,EPE - Hospital de Santa Maria - PPDS

    Lisbon, Portugal · Recruiting

  • ULS de Santo António, EPE - Centro Materno Infantil Norte

    Porto, Porto District, Portugal · Recruiting

  • Hospital Universitario Vall d'Hebron - PPDS

    Barcelona, Barcelona, Spain · Recruiting

  • Hospital Infantil Universitario Niño Jesus - PIN

    Madrid, Madrid, Spain · Recruiting

  • Sahlgrenska universitetssjukhuset Östra

    Gothenburg, Västra Götaland County, Sweden · Active not recruiting

  • Inselspital - Universitätsspital Bern

    Bern, Canton of Bern, Switzerland · Recruiting

  • Cukurova Universitesi Balcali Hastanesi Saglik Uygulama ve Arastirma Merkezi

    Adana, Adana, Turkey (Türkiye) · Recruiting

  • Gazi Universitesi Saglik Arastirma ve Uygulama Merkezi

    Çankaya, Ankara, Turkey (Türkiye) · Recruiting

  • Ege Universitesi Tip Fakultesi

    Bornova, İzmir, Turkey (Türkiye) · Recruiting

  • Royal Manchester Children's Hospital

    Manchester, United Kingdom · Recruiting

  • Great Ormond Street Hospital

    London, London, United Kingdom · Recruiting

  • University College London Hospitals (UCLH)

    London, Middlesex, United Kingdom · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.